The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer
FOXC2, a member of the forkhead box family of transcription factors, is an emerging oncogene that has been linked to several hallmarks of cancer progression. Among its many oncogenic functions is the promotion of drug resistance, with evidence supporting roles for FOXC2 in escape from broad classes...
Main Authors: | Kristian M. Hargadon PhD, Elijah W. Strong BS |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-02-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338231155284 |
Similar Items
-
RNA-seq Analysis of Wild-Type vs. FOXC2-Deficient Melanoma Cells Reveals a Role for the FOXC2 Transcription Factor in the Regulation of Multiple Oncogenic Pathways
by: Kristian M. Hargadon, et al.
Published: (2020-02-01) -
Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer
by: Feikai Lin, et al.
Published: (2022-04-01) -
Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation
by: Pieter R Norden, et al.
Published: (2020-06-01) -
Regulation and Function of FOXC1 in Osteoblasts
by: Sarocha Suthon, et al.
Published: (2023-09-01) -
Data supporting the regulation of FOXC2 in podocyte dysfunction
by: Neeta Datta, et al.
Published: (2016-03-01)